[1] |
SIEGEL R L, MILLER K D, JEMAL A. Cancer statistics,2020[J]. CA Cancer J Clin, 2020, 70(1):7-30.
|
[2] |
DESANTIS C E, MA J, GAUDET M M, et al. Breast cancer statistics,2019[J]. CA Cancer J Clin, 2019, 69(6):438-451.
|
[3] |
ELINAV E, NOWARSKI R, THAISS C A, et al. Inflammation-induced cancer:crosstalk between tumors,immune cells and microorganisms[J]. Nat Rev Cancer, 2013, 13(11):759-771.
|
[4] |
郭奕阳, 邓艳丽, 郭秀娟, 等. 乳腺癌患者HER-2胞外结构域的临床价值[J]. 检验医学, 2017, 32(10):871-874.
|
[5] |
赵卫卫, 肖林林, 刘秀芬, 等. 术前外周血中性粒细胞/淋巴细胞比值在乳腺癌诊断中的作用[J]. 检验医学, 2018, 33(3):209-212.
|
[6] |
OKTAY K, SANTALIZ-CASIANO A, PATEL M, et al. A computational statistics approach to evaluate blood biomarkers for breast cancer risk stratification[J]. Horm Cancer, 2020, 11(1):17-33.
|
[7] |
陈力, 孔祥溢, 方仪, 等. 外周血中常见血液学参数对乳腺癌预后评估价值的研究进展[J]. 现代生物医学进展, 2019, 19(23):4582-4585.
|
[8] |
钟田花, 王文强, 陈振辉, 等. 乳腺癌患者血小板/淋巴细胞比值及红细胞分布宽度检测的临床价值[J]. 海南医学, 2018, 29(16):2284-2287.
|
[9] |
YAO D, WANG Z, CAI H, et al. Relationship between red cell distribution width and prognosis in patients with breast cancer after operation:a retrospective cohort study[J]. Biosci Rep, 2019, 39(7):BSR20190740.
|
[10] |
SERETIS C, SERETIS F, LAGOUDIANAKIS E, et al. Is red cell distribution width a novel biomarker of breast cancer activity? Data from a pilot study[J]. J Clin Med Res, 2013, 5(2):121-126.
|
[11] |
TAKEUCHI H, ABE M, TAKUMI Y, et al. Elevated red cell distribution width to platelet count ratio predicts poor prognosis in patients with breast cancer[J]. Sci Rep, 2019, 9(1):3033.
|
[12] |
TAKEUCHI H, ABE M, TAKUMI Y, et al. The prognostic impact of the platelet distribution width-to-platelet count ratio in patients with breast cancer[J]. PLoS One, 2017, 12(12):e0189166.
|
[13] |
SAKIN A, SAHIN S, SAKIN A, et al. Mean platelet volume and platelet distribution width correlates with prognosis of early colon cancer[J]. J BUON, 2020, 25(1):227-239.
|
[14] |
YUE C X, LIU Y X, YUN Z Y, et al. Decreased platelet distribution width predicts a worse prognosis in patients undergoing surgical resection for hepatocellular carcinoma[J]. Cancer Biomark, 2019, 26(3):361-366.
|